Age 0 3 0 3 B-age
18 4 6 4 6 B-lower_bound
years 7 12 7 12 I-lower_bound
or 13 15 13 15 O
older 16 21 16 21 O

Bifurcation 0 11 22 33 B-chronic_disease
lesion 12 18 34 40 I-chronic_disease
requiring 19 28 41 50 O
2 29 30 51 52 O
stenting 31 39 53 61 B-treatment
technique 40 49 62 71 O

Bypass 0 6 72 78 B-treatment
graft 7 12 79 84 I-treatment
lesion 13 19 85 91 O

Contraindication 0 16 92 108 O
to 17 19 109 111 O
or 20 22 112 114 O
planned 23 30 115 122 O
discontinuation 31 46 123 138 O
of 47 49 139 141 O
dual 50 54 142 146 B-treatment
antiplatelet 55 67 147 159 I-treatment
therapy 68 75 160 167 I-treatment
within 76 82 168 174 O
1 83 84 175 176 B-upper_bound
year 85 89 177 181 I-upper_bound

Lesion 0 6 182 188 B-clinical_variable
length 7 13 189 195 I-clinical_variable
≤ 14 15 196 197 O
40 16 18 198 200 B-upper_bound

Life 0 4 201 205 B-clinical_variable
expectancy 5 15 206 216 I-clinical_variable
less 16 20 217 221 O
than 21 25 222 226 O
2 26 27 227 228 B-upper_bound
years 28 33 229 234 I-upper_bound

Lipid 0 5 235 240 O
- 5 6 240 241 O
rich 6 10 241 245 O
plaque 11 17 246 252 O
on 18 20 253 255 O
NIRS(Intracoronary 21 39 256 274 O
Near 40 44 275 279 O
- 44 45 279 280 O
Infrared 45 53 280 288 O
Spectroscopy 54 66 289 301 O
) 66 67 301 302 O
( 68 69 303 304 O
defined 69 76 304 311 O
as 77 79 312 314 O
maxLCBI4mm>315 80 94 315 329 B-clinical_variable
) 94 95 329 330 O

MLA(minimal 0 11 331 342 B-clinical_variable
luminal 12 19 343 350 I-clinical_variable
area)<4mm2 20 30 351 361 I-clinical_variable

Patients 0 8 362 370 O
having 9 15 371 377 O
at 16 18 378 380 O
least 19 24 381 386 O
one 25 28 387 390 B-lower_bound
significant 29 40 391 402 O
stenosis 41 49 403 411 B-chronic_disease
( 50 51 412 413 O
diameter 51 59 413 421 B-clinical_variable
stenosis 60 68 422 430 I-clinical_variable
> 69 70 431 432 O
50 71 73 433 435 B-lower_bound
% 73 74 435 436 I-lower_bound
) 74 75 436 437 O
with 76 80 438 442 O
FFR 81 84 443 446 B-clinical_variable
> 85 86 447 448 O
0.80 86 90 448 452 B-lower_bound
and 91 94 453 456 O
meeting 95 102 457 464 O
two 103 106 465 468 O
of 107 109 469 471 O
the 110 113 472 475 O
following 114 123 476 485 O

Patients 0 8 486 494 O
in 9 11 495 497 O
whom 12 16 498 502 O
the 17 20 503 506 O
preferred 21 30 507 516 O
treatment 31 40 517 526 B-treatment
is 41 43 527 529 O
CABG(Coronary 44 57 530 543 B-treatment
artery 58 64 544 550 I-treatment
bypass 65 71 551 557 I-treatment
grafting 72 80 558 566 I-treatment
) 80 81 566 567 I-treatment

Planned 0 7 568 575 O
cardiac 8 15 576 583 B-treatment
surgery 16 23 584 591 I-treatment
or 24 26 592 594 O
planned 27 34 595 602 O
major 35 40 603 608 B-treatment
non 41 44 609 612 I-treatment
cardiac 45 52 613 620 I-treatment
surgery 53 60 621 628 I-treatment

Reference 0 9 629 638 O
vessel 10 16 639 645 B-clinical_variable
diameter 17 25 646 654 I-clinical_variable
2.75 26 30 655 659 B-lower_bound
- 30 31 659 660 O
4.0 31 34 660 663 B-upper_bound

Stented 0 7 664 671 B-chronic_disease
lesion 8 14 672 678 I-chronic_disease

Symptomatic 0 11 679 690 O
or 12 14 691 693 O
asymptomatic 15 27 694 706 O
coronary 28 36 707 715 B-chronic_disease
artery 37 43 716 722 I-chronic_disease
disease 44 51 723 730 I-chronic_disease
patients 52 60 731 739 O

TCFA(thin 0 9 740 749 B-chronic_disease
- 9 10 749 750 I-chronic_disease
cap 10 13 750 753 I-chronic_disease
fibroatheroma 14 27 754 767 I-chronic_disease
) 27 28 767 768 I-chronic_disease
defined 29 36 769 776 O
by 37 39 777 779 O
OCT(fibrous 40 51 780 791 O
cap 52 55 792 795 I-clinical_variable
thickness<65 56 68 796 808 I-clinical_variable
µm 68 70 808 810 I-upper_bound
and 71 74 811 814 O
arc>90 75 81 815 821 B-clinical_variable
° 81 82 821 822 I-lower_bound
) 82 83 822 823 O

The 0 3 824 827 O
patients 4 12 828 836 O
who 13 16 837 840 O
have 17 21 841 845 O
more 22 26 846 850 O
than 27 31 851 855 O
or 32 34 856 858 O
equal 35 40 859 864 O
to 41 43 865 867 O
3 44 45 868 869 B-lower_bound
target 46 52 870 876 B-clinical_variable
lesions 53 60 877 884 I-clinical_variable

VH 0 2 885 887 B-clinical_variable
- 2 3 887 888 I-clinical_variable
IVUS≥10 3 10 888 895 I-clinical_variable
% 10 11 895 896 I-lower_bound
confluent 12 21 897 906 O
NC 22 24 907 909 B-clinical_variable
with>30 25 32 910 917 O
° 32 33 917 918 I-lower_bound
abutting 34 42 919 927 O
to 43 45 928 930 O
the 46 49 931 934 O
lumen 50 55 935 940 O
in 56 58 941 943 O
3 59 60 944 945 O
consecutive 61 72 946 957 O
slices 73 79 958 964 O
) 79 80 964 965 O

Woman 0 5 966 971 B-gender
who 6 9 972 975 O
are 10 13 976 979 O
breastfeeding 14 27 980 993 O
, 27 28 993 994 O
pregnant 29 37 995 1003 B-pregnancy
or 38 40 1004 1006 O
planning 41 49 1007 1015 B-pregnancy
to 50 52 1016 1018 I-pregnancy
become 53 59 1019 1025 I-pregnancy
pregnant 60 68 1026 1034 I-pregnancy
during 69 75 1035 1041 O
the 76 79 1042 1045 O
course 80 86 1046 1052 O
of 87 89 1053 1055 O
the 90 93 1056 1059 O
study 94 99 1060 1065 O

plaque 0 6 1066 1072 B-clinical_variable
burden>70 7 16 1073 1082 I-clinical_variable
% 16 17 1082 1083 I-lower_bound

